Harlan S Robins
Chief Scientific Officer at Adaptive Biotechnologies. Based in Seattle, Washington.
- Rank
- 4700th of 14,452
- Companies held
- 1
- Largest holding
- ADPT, 100.0% of total
- Latest SEC filing
- Jul 21, 2026
What the $22.8M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Adaptive Biotechnologies ADPT Common Stock | Directly | 812,058 | $28.05 | $22.8M | 100.0% | Form 4, Jul 21, 2026 |
Share counts are the amounts Harlan S Robins reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 21, 2026 | Sold | ADPT | 213,702 | $22.12 | $4.7M | View |
| Jul 21, 2026 | Sold | ADPT | 278,698 | $21.72 | $6.1M | View |
| Jul 2, 2026 | Sold | ADPT | 239,351 | $21.74 | $5.2M | View |
| Jul 2, 2026 | Sold | ADPT | 146,889 | $22.45 | $3.3M | View |
| Jun 16, 2026 | Sold | ADPT | 6,160 | $18.01 | $111K | View |
| Jun 15, 2026 | Sold | ADPT | 100,000 | $17.37 | $1.7M | View |
| Apr 8, 2026 | Sold | ADPT | 10,000 | $14.85 | $149K | View |
| Mar 11, 2026 | Sold | ADPT | 329,600 | $13.17 | $4.3M | View |
| Mar 11, 2026 | Sold | ADPT | 140,666 | $13.17 | $1.9M | View |
| Mar 3, 2026 | Sold | ADPT | 14,233 | $16.52 | $235K | View |
| Mar 2, 2026 | Sold | ADPT | 10,000 | $15.72 | $157K | View |
| Feb 3, 2026 | Sold | ADPT | 8,120 | $19.00 | $154K | View |
| Feb 2, 2026 | Sold | ADPT | 34,668 | $18.60 | $645K | View |
| Jan 6, 2026 | Sold | ADPT | 10,000 | $16.44 | $164K | View |
| Dec 4, 2025 | Sold | ADPT | 10,000 | $16.61 | $166K | View |
| Dec 3, 2025 | Sold | ADPT | 27,212 | $18.61 | $506K | View |
| Nov 10, 2025 | Sold | ADPT | 10,000 | $14.82 | $148K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4697 | Stephanie Carullo Chief Operating Officer, Box. Redwood City, CA | $22.8M |
| 4698 | John W. Altmeyer Director, EMCOR Group. Mechanicsburg, PA | $22.8M |
| 4699 | William M. Foshee CFO, EVP, ServisFirst Bancshares. Birmingham, AL | $22.8M |
| 4700 | Harlan S Robins Chief Scientific Officer, Adaptive Biotechnologies. Seattle, WA | $22.8M |
| 4701 | David Pendarvis Chief Administrative Officer, ResMed. San Diego, CA | $22.8M |
| 4702 | Joseph J. Wolk Exec VP, CFO, Johnson & Johnson. New Brunswick, NJ | $22.8M |
| 4703 | Christophe Beck CHAIRMAN, PRESIDENT & CEO, Ecolab. St. Paul, MN | $22.8M |
Other Adaptive Biotechnologies insiders
All ADPT insiders- Chad M. Robins$58.4MCEO and Chairman. #2282 overall
- Tycho Peterson$14.9MChief Financial Officer. #6474 overall
- Susan Bobulsky$10.9MChief Commercial Officer, MRD. #8230 overall
- Julie Rubinstein$10.6MPresident and COO. #8404 overall
- Kyle Piskel$7.2MChief Financial Officer. #11185 overall
- Francis Lo$6.3MChief People Officer. #12389 overall
Questions
How much stock does Harlan S Robins own?
Harlan S Robins holds $22,778,227 in listed stock based on SEC filings and current prices, mostly Adaptive Biotechnologies (ADPT). That ranks 4700th on the Stock Rich List.
Is this Harlan S Robins's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Harlan S Robins last buy or sell stock?
The most recent open-market trade on file is a sale of 213,702 ADPT shares on Jul 21, 2026 at $22.12.